Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center.
Rev Invest Clin
; 74(1): 16-22, 2022 01 03.
Article
in English
| MEDLINE | ID: covidwho-1399761
ABSTRACT
BACKGROUND:
The impact of coronavirus disease-19 on the management of multiple myeloma (MM) has been recognized. However, the real effect on clinical outcomes remains poorly understood.OBJECTIVE:
We describe a local experience of the management of MM patients and report their outcomes during the current pandemic.METHODS:
All consecutive symptomatic MM patients seen at our center since 03/20 were evaluated.RESULTS:
A cohort of 156 patients diagnosed from 01/19 to 12/20 was analyzed to interrogate differences in presentation patterns. A total of 553 MM patients were seen and/or treated at Tom Baker Cancer Center in the year of 2020. From those, 47.1% (n = 261) were tested for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Sixteen patients tested positive and data are presented. In addition, a decrease of 21.7% in the rate of new smoldering MM/MM diagnosis was observed in 2020 as compared to 2019. Further, an increase in deaths was also observed in 2020.CONCLUSIONS:
Our study confirms an increase lethality for MM patients infected with SARS-CoV-2. A balance between safety and need for cancer control should be emphasized.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Myeloma
Type of study:
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Rev Invest Clin
Journal subject:
Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Ric.21000347
Similar
MEDLINE
...
LILACS
LIS